Can serum glial fibrillary acidic protein (GFAP) solve the longstanding problem of diagnosis and monitoring progressive multiple sclerosis

被引：2

作者：

Groen, Kira ^{[1
,2
]}

Lechner-Scott, Jeannette ^{[1
,2
]}

Pohl, Daniela ^{[3
]}

Levy, Michael ^{[4
]}

Giovannoni, Gavin ^{[5
]}

Hawkes, Chris ^{[6
]}

机构：

[1] Univ Newcastle, Hunter Med Researc Inst, Newcastle, NSW, Australia

[2] Hunter New England Area Hlth, Newcastle, NSW, Australia

[3] Univ Ottawa, Ottawa, ON, Canada

[4] Harvard Univ, Cambridge, MA 02138 USA

[5] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Dept Neurol, London, England

[6] Queen Mary Univ London, Dept Neurol, Neurosci Ctr, London, England

来源：

MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2021年 / 50卷

关键词：

WHITE-MATTER LESIONS; NEUROMYELITIS-OPTICA; SPECTRUM;

D O I：

10.1016/j.msard.2021.102931

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页数：2

共 50 条

[31] Increased serum glial fibrillary acidic protein (GFAP) levels predict disease progression in B cell depleted patients with progressive MS
Benkert, P.
Maceski, A.
Lorscheider, J.
Schaedelin, S.
Willemse, E. A. J.
Meier, S.
Gress, U.
Melie-Garcia, L.
Cagol, A.
Galbusera, R.
Subramaniam, S.
Barakovic, M.
Achtnichts, L.
Lalive, P.
Mueller, S.
Pot, C.
Salmen, A.
Disanto, G.
Zecca, C.
Orleth, A.
Yaldizli, O.
Derfuss, T.
Oechtering, J.
Piehl, F.
Kappos, L.
Gobbi, C.
Granziera, C.
Leppert, D.
Bridel, C.
Kuhle, J.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 592 - 593
[32] Serum Glial Fibrillary Acidic Protein Level Predicts Worsening Disability, Future Need for Gait Aid, and Conversion to Progressive Disease in Multiple Sclerosis
Madill, Evan
Healy, Brian
Polgar-Turcsanyi, Mariann
Weiner, Howard
Chitnis, Tanjua
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 58 - 59
[33] Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4
Kessler, Christoph
Ruschil, Christoph
Abdelhak, Ahmed
Wilke, Carlo
Maleska, Aleksandra
Kuhle, Jens
Krumbholz, Markus
Kowarik, Markus C.
Schuele, Rebecca
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
[34] Serum concentrations of glial fibrillary acidic protein (GFAP) do not indicate tumor recurrence in patients with glioblastoma
Julia-Mareen Vietheer
Johannes Rieger
Marlies Wagner
Christian Senft
Julia Tichy
Christian Foerch
Journal of Neuro-Oncology, 2017, 135 : 193 - 199
[35] Serum glial fibrillary acidic protein compared with neurofilament light chain as biomarker for multiple sclerosis disease progression
Meier, S.
Benkert, P.
Maceski, A.
Schaedelin, S.
Garcia, L. Melie
Cagol, A.
Barakovic, M.
Galbusera, R.
Subramaniam, S.
Achtnichts, L.
Lalive, P. H.
Bridel, C.
Muller, S.
Pot, C.
Salmen, A.
Disanto, G.
Zecca, C.
Orleth, A.
Khalil, M.
Yaldizli, O.
Oechtering, J.
Battaglini, M.
Kappos, L.
Derfuss, T.
Leppert, D.
Gobbi, C.
Granziera, C.
Willemse, E. A. J.
Kuhle, J.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 122 - 123
[36] Serum concentrations of glial fibrillary acidic protein (GFAP) do not indicate tumor recurrence in patients with glioblastoma
Vietheer, Julia-Mareen
Rieger, Johannes
Wagner, Marlies
Senft, Christian
Tichy, Julia
Foerch, Christian
JOURNAL OF NEURO-ONCOLOGY, 2017, 135 (01) : 193 - 199
[37] LONGITUDINAL CHARACTERIZATION OF SERUM GLIAL FIBRILLARY ACIDIC PROTEIN AND ANTI-GFAP AUTOANTIBODIES AFTER TBI
Wiener, Joshua
Vaughan, Leah
Yang, Zhihui
Xu, Haiyan
Williamson, John
Robertson, Claudia
Rubenstein, Richard
Wang, Kevin
Wagner, Amy
JOURNAL OF NEUROTRAUMA, 2021, 38 (14) : A25 - A25
[38] Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis
Meier, Stephanie
Willemse, Eline A. J.
Schaedelin, Sabine
Oechtering, Johanna
Lorscheider, Johannes
Melie-Garcia, Lester
Cagol, Alessandro
Barakovic, Muhamed
Galbusera, Riccardo
Subramaniam, Suvitha
Barro, Christian
Abdelhak, Ahmed
Thebault, Simon
Achtnichts, Lutz
Lalive, Patrice
Muller, Stefanie
Pot, Caroline
Salmen, Anke
Disanto, Giulio
Zecca, Chiara
D'Souza, Marcus
Orleth, Annette
Khalil, Michael
Buchmann, Arabella
Du Pasquier, Renaud
Yaldizli, Ozgur
Derfuss, Tobias
Berger, Klaus
Hermesdorf, Marco
Wiendl, Heinz
Piehl, Fredrik
Battaglini, Marco
Fischer, Urs
Kappos, Ludwig
Gobbi, Claudio
Granziera, Cristina
Bridel, Claire
Leppert, David
Maceski, Aleksandra Maleska
Benkert, Pascal
Kuhle, Jens
JAMA NEUROLOGY, 2023, 80 (03) : 287 - 297
[39] Serum Glial Fibrillary Acidic Protein compared with Neurofilament Light Chain as Biomarker for Multiple Sclerosis Disease Progression
Meier, Stephanie
Benkert, Pascal
Maceski, Aleksandra Maleska
Schaedelin, Sabine
Oechtering, Johanna
Melie-Garcia, Lester
Cagol, Alessandro
Barakovic, Muhamed
Galbusera, Riccardo
Achtnichts, Lutz
Lalive, Patrice H.
Bridel, Claire
Mueller, Stefanie
Pot, Caroline
Salmen, Anke
Disanto, Giulio
Zecca, Chiara
Abdelhak, Ahmed
Barro, Christian
Thebault, Simon
D'Souza, Marcus
Derfuss, Tobias
Orleth, Annette
Khalil, Michael
Yaldizli, Ozguer
Hermesdorf, Marco
Wiendl, Heinz
Piehl, Fredrik
Fischer, Urs
Kappos, Ludwig
Gobbi, Claudio
Granziera, Cristina
Leppert, David
Willemse, Eline A. J.
Kuhle, Jens
NEUROLOGY, 2023, 100 (17)
[40] Plasma Glial Fibrillary Acidic Protein Correlates with Characteristics of Advanced Disease and Treatment Response in Secondary Progressive Multiple Sclerosis
Kuhle, Jens
Kropshofer, Harald
Maceski, Aleksandra Maleska
Dahlke, Frank
Hach, Thomas
Tomic, Davorka
Kappos, Ludwig
Leppert, David
NEUROLOGY, 2020, 94 (15)

← 1 2 3 4 5 →